Cue Health Inc. (HLTH)
- Previous Close
0.1446 - Open
0.1520 - Bid --
- Ask --
- Day's Range
0.1420 - 0.1533 - 52 Week Range
0.1420 - 1.1200 - Volume
279,761 - Avg. Volume
506,703 - Market Cap (intraday)
22.509M - Beta (5Y Monthly) 1.22
- PE Ratio (TTM)
-- - EPS (TTM)
-2.4400 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.75
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
www.cuehealth.com726
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HLTH
Performance Overview: HLTH
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HLTH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HLTH
Valuation Measures
Market Cap
22.51M
Enterprise Value
-10.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.34
Price/Book (mrq)
0.09
Enterprise Value/Revenue
-0.16
Enterprise Value/EBITDA
0.03
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-31.88%
Return on Equity (ttm)
-90.35%
Revenue (ttm)
70.94M
Net Income Avi to Common (ttm)
-373.46M
Diluted EPS (ttm)
-2.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
80.89M
Total Debt/Equity (mrq)
19.16%
Levered Free Cash Flow (ttm)
-4.15M
Research Analysis: HLTH
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell